mRNA-Loaded DC Vaccine

About Transimmune

Transimmune is a private, pre-clinical stage biotech leveraging a novel dendritic cell platform derived from the mechanistic understanding of Extracorporeal Photopheresis (ECP). Its core technology uses platelet-activated monocytes to generate dendritic cells in hours, promising enhanced potency and point-of-care manufacturing. The company is advancing programs in cancer and infectious disease vaccines, backed by grants and collaborations with academic institutions and industry partners like Mallinckrodt.

Therapeutic Areas